Today: 16 April 2026
Subscribe
Browse Category

Artificial Intelligence 12 June 2025

Generative AI Revolution: 2025 Breakthroughs, Industry Disruption, and Predictions Through 2035

Generative AI Revolution: 2025 Breakthroughs, Industry Disruption, and Predictions Through 2035

OpenAI launched GPT-4.5 “Orion” on February 27, 2025, its largest model yet. Google, Meta, Anthropic, and Amazon also released new AI systems in early 2025, including Gemini 2.5, Llama 4, Claude 3.7, and Amazon Nova. The global generative AI market is projected to hit $32 billion in 2025, with over 78% of organizations using AI. The EU AI Act’s GPAI rules start applying in August 2025.
12 June 2025
····
Artificial Intelligence in Satellite and Space Systems

Artificial Intelligence in Satellite and Space Systems

In 2013, JAXA’s Epsilon rocket became the first AI-enabled launch vehicle, cutting launch prep from months to days. NASA’s Perseverance rover used AutoNav in 2021 to drive up to five times faster than Curiosity. ESA’s Φ-sat-2 CubeSat, launched in 2024, carries six onboard AI apps and can upload new models after launch. SpaceX’s Starlink satellites now autonomously dodge debris using onboard sensors.
12 June 2025
··
1 … 164 165 166

Stock Market Today

  • Alkane Resources Joins S&P/ASX 200, Boosted by Strategic Moves and Strong Quarter
    April 15, 2026, 10:08 PM EDT. Alkane Resources Ltd (ASX:ALK) will join the S&P/ASX 200 index on April 22, replacing National Storage REIT. This inclusion reflects Alkane's growth driven by managing director Nic Earner. Key developments include advancing a joint venture with Nagambie Resources Ltd via a $2.5 million share subscription, granting Alkane exploration rights in Nagambie's mining licenses. Alkane secured a A$150 million syndicated debt package to enhance financial flexibility, following early repayment of a $45 million facility in August 2025. The company posted a strong March quarter, producing 45,776 ounces of gold equivalent from three mines. Cash, bullion, and investments rose to $374 million, underpinned by robust cash flow and disciplined capital management. Alkane remains nearly debt free aside from $20 million in equipment financing.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Go toTop